Literature DB >> 24882979

A Recurrent Angiosarcoma Isolated to the Eyelid without the Recurrence on the Primary Lesion of the Forehead.

Jung Eun Kim1, Byung Jik Kim1, Hoon Kang1.   

Abstract

Angiosarcoma is a highly malignant vascular tumor of endothelial origin. Initially, a cutaneous manifestation presents as a singular or multifocal bruise-like patches on the skin, most frequently on the face, the scalp or the neck regions. On progression, the lesions become violaceous, and ill-defined spongy nodular tumors appear. Our patient was a 71-year-old man with a previous history of angiosarcoma on the right forehead and was treated with an excision and local radiation 3 years ago. Several months after the treatment, a dark brownish to violaceous patch with edema arose from the right upper eyelid and spread out to the lower eyelid. Clinically, an ecchymosis caused by trauma or other hemangioma was suspected more than a recurrent angiosarcoma. Histopathologic examinations including immunohistochemical studies were consistent with cutaneous angiosarcoma. Herein, we report a rare case of a recurrent isolated angiosarcoma without the recurrence of a primary lesion.

Entities:  

Keywords:  Angiosarcoma; Ecchymosis; Eyelids

Year:  2014        PMID: 24882979      PMCID: PMC4037677          DOI: 10.5021/ad.2014.26.2.231

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  13 in total

1.  Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy.

Authors:  Christopher K Fuller; John A Charlson; Steven K Dankle; Thomas J Russell
Journal:  J Am Acad Dermatol       Date:  2010-10       Impact factor: 11.527

2.  Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face.

Authors:  A Rosen; S Thimon; D Ternant; M C Machet; G Paintaud; L Machet
Journal:  Br J Dermatol       Date:  2010-04-12       Impact factor: 9.302

3.  Cutaneous angiosarcoma of the eyelids.

Authors:  R M Conway; T Hammer; A Viestenz; L M Holbach; R M Conway
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  An erythematous nodule on the eyelid.

Authors:  A Mitra; R Ramnath; S Nicholson; A Yung
Journal:  Clin Exp Dermatol       Date:  2007-05-14       Impact factor: 3.470

5.  Angiosarcoma of the eyelid: yellow plaques causing ptosis.

Authors:  C S Lapidus; F C Sutula; M J Stadecker; J E Vine; D J Grande
Journal:  J Am Acad Dermatol       Date:  1996-02       Impact factor: 11.527

Review 6.  Cutaneous angiosarcoma.

Authors:  William M Mendenhall; Charles M Mendenhall; John W Werning; John D Reith; Nancy P Mendenhall
Journal:  Am J Clin Oncol       Date:  2006-10       Impact factor: 2.339

7.  Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.

Authors:  Sheri L DeMartelaere; Dianna Roberts; Michael A Burgess; William H Morrison; Peter W T Pisters; Erich M Sturgis; Viet Ho; Bita Esmaeli
Journal:  Head Neck       Date:  2008-05       Impact factor: 3.147

8.  Cutaneous angiosarcoma with eyelid involvement.

Authors:  K Gündüz; J A Shields; C L Shields; R C Eagle; F Nathan
Journal:  Am J Ophthalmol       Date:  1998-06       Impact factor: 5.258

9.  Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.

Authors:  Bridget F Koontz; Edward F Miles; Mary Ann D Rubio; John F Madden; Samuel R Fisher; Richard L Scher; David M Brizel
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

10.  Angiosarcoma of the eyelid and periorbital region. Experience in Leiden with iridium192 brachytherapy and low-dose doxorubicin chemotherapy.

Authors:  R J W de Keizer; D de Wolff-Rouendaal; M A Nooy
Journal:  Orbit       Date:  2008
View more
  4 in total

1.  Primary Angiosarcoma of the Skin Presenting as Mild Erythema.

Authors:  Sun Young Moon; Dong Hyuk Eun; Yong Hyun Jang; Seok-Jong Lee; Do Won Kim; Weon Ju Lee
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

2.  Exuberant angiosarcoma.

Authors:  Amanda Brilhante Pontes; Juliana Lacerda Reis Ucelli; Daniel Lago Obadia; Leninha Valério do Nascimento
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

3.  Clinical and dermoscopic features of atypical abdominal brachytherapy-induced angiosarcoma.

Authors:  Beata Bergler-Czop; Karolina Hadasik; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2016-08-16       Impact factor: 1.837

4.  The Eyelid Angiosarcoma: A Systematic Review of Characteristics and Clinical Course.

Authors:  Gyudeok Hwang; Jeongah Shin; Ji-Young Lee; Kyung-Sun Na; Ji-Sun Paik; Hyeon Woo Yim; Suk-Woo Yang; Won-Kyung Cho
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.